POINT Biopharma Global Overview
POINT Biopharma Global Price to Sales
Price-to-Sales ratio (P/S) for PNT.
Get informed when a big investor buys or sells
+ FollowPrice to Sales
6.25
Price to Sales
6.25
Price-to-Sales ratio compares a company's stock price to its revenue per share. A lower P/S ratio may indicate that the stock is undervalued relative to its sales.
Average Price to Sales (Comparison Companies)
Price to Sales History
Price to Sales Comparison